Correlation Between Talanx AG and Merck
Can any of the company-specific risk be diversified away by investing in both Talanx AG and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talanx AG and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talanx AG and Merck Company, you can compare the effects of market volatilities on Talanx AG and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talanx AG with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talanx AG and Merck.
Diversification Opportunities for Talanx AG and Merck
Excellent diversification
The 3 months correlation between Talanx and Merck is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Talanx AG and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Talanx AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talanx AG are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Talanx AG i.e., Talanx AG and Merck go up and down completely randomly.
Pair Corralation between Talanx AG and Merck
Assuming the 90 days horizon Talanx AG is expected to generate 1.16 times more return on investment than Merck. However, Talanx AG is 1.16 times more volatile than Merck Company. It trades about 0.27 of its potential returns per unit of risk. Merck Company is currently generating about -0.16 per unit of risk. If you would invest 7,300 in Talanx AG on October 9, 2024 and sell it today you would earn a total of 995.00 from holding Talanx AG or generate 13.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 97.37% |
Values | Daily Returns |
Talanx AG vs. Merck Company
Performance |
Timeline |
Talanx AG |
Merck Company |
Talanx AG and Merck Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Talanx AG and Merck
The main advantage of trading using opposite Talanx AG and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talanx AG position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.Talanx AG vs. ONWARD MEDICAL BV | Talanx AG vs. PEPTONIC MEDICAL | Talanx AG vs. CREO MEDICAL GRP | Talanx AG vs. AFFLUENT MEDICAL SAS |
Merck vs. Daito Trust Construction | Merck vs. Harmony Gold Mining | Merck vs. ARDAGH METAL PACDL 0001 | Merck vs. MAGNUM MINING EXP |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |